Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03760211 · ClinicalTrials.gov registry record · NA

A Mobile Gaming App to Improve ART Adherence for Youth

A NA study, sponsored by Rhode Island Hospital.

Completed
Registry status
NA
Development phase
107
Enrollment target

NCT03760211: Completed NA study, sponsored by Rhode Island Hospital.

NCT03760211 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 107 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03760211, a NA study, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target

Study Summary

Despite the need for consistent adherence to medical care, youth living with HIV have low rates of adherence to medications and treatment. There are few interventions to improve adherence to HIV medications and treatment for youth, and there is a great need for novel approaches that are engaging for this age group. The investigators developed an intervention that includes a mobile gaming app that is integrated with a 7-day electronic medication device and text messages. During gameplay, youth fight HIV in colorful organ systems. A small previous project found that the intervention helped youth who were newly starting medications for HIV by improving adherence and decreasing HIV virus in their bodies (viral load). This proposed project will test the intervention with larger number of youth (100) who are newly starting HIV treatment and medications in New England, Georgia, and in Mississippi. The investigators want to determine if adherence is improved and viral load is reduced in this larger sample.

Primary Outcome

Assessing change from Baseline HIV-1 viral load (copies/mL)

Interventions

  • BEHAVIORAL Multilevel Gaming Adherence Intervention
  • BEHAVIORAL Treatment as Usual +

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2019-11-01
Est. Completion 2024-10-17
Phase NA
Rhode Island Hospital

130 total trials

What the finished NCT03760211 record still lists

NCT03760211 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Multilevel Gaming Adherence Intervention is the first listed.

NCT03760211 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03760211 about?

NCT03760211 is a clinical study titled "A Mobile Gaming App to Improve ART Adherence for Youth". Despite the need for consistent adherence to medical care, youth living with HIV have low rates of adherence to medications and treatment. There are few interventions to improve adherence to HIV medications and treatment for youth, and there is a great need for novel approaches that are engaging for...

What is the current status of trial NCT03760211?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2019-11-01. Estimated completion is 2024-10-17.

What interventions are being tested in trial NCT03760211?

The interventions under investigation include: Multilevel Gaming Adherence Intervention (BEHAVIORAL), Treatment as Usual + (BEHAVIORAL).

Who is sponsoring clinical trial NCT03760211?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03760211's enrollment target sits among peer trials

107 830th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491668 · 107 participants

    Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03760211, the US trial registry maintained by the National Library of Medicine. NCT03760211 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.